Publications and Further Research Outputs
- Power R, Leavy C, Nolan C, White N, Clarke R, Cadoo KA, Gallagher DJ, Lowery MA, Prevalence of pancreaticobiliary cancers in Irish families with pathogenic BRCA1 and BRCA2 variants., Familial cancer, 2020Journal Article, 2020
- McNevin CS, Cadoo K, Baird AM, Murchan P, Sheils O, McDermott R, Finn S., Pathogenic BRCA Variants as Biomarkers for Risk in Prostate Cancer., Cancers, 13, (22), 2021Journal Article, 2021, DOI
- Anne-Marie Baird, Ciara S. McNevin, Karen Cadoo, Anne-Marie Baird, Stephen Finn, Ray McDermott, PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures, Cancers, 14, (19), 2022, p4751Journal Article, 2022, DOI
- LEWIS, F., BEIRNE, J., HENDERSON, B., NORRIS, L., CADOO, K., KELLY, T., MARTIN, C., HURLEY, S., KANJUGA, M., O'DRISCOLL, L., GATELY, K., ONER, E., SAINI, V. M., BROOKS, D., SELEMIDIS, S., KAMRAN, W., HAUGHEY, N., MAGUIRE, P., O'GORMAN, C., SAADEH, F. A., WARD, M. P., O'LEARY, J. J. & O'TOOLE, S. A., Unravelling the biological and clinical challenges of circulating tumour cells in epithelial ovarian carcinoma, Cancer Letters, 2024Journal Article, 2024, DOI
- Power R.F., Doherty D.E., Horgan R., Fahey P., Gallagher D.J., Lowery M.A., Cadoo K.A., Modifiable risk factors for cancer among people with lynch syndrome: an international, cross-sectional survey, Hereditary Cancer in Clinical Practice, 22, (1), 2024Journal Article, 2024, DOI
- Power R.F., Doherty D.E., Parker I., Gallagher D.J., Lowery M.A., Cadoo K.A., Modifiable Risk Factors and Risk of Colorectal and Endometrial Cancers in Lynch Syndrome: A Systematic Review and Meta-Analysis, JCO Precision Oncology, 8, 2024Review, 2024, DOI
- Mark P. Ward, F. Park Lewis, C. O"Gorman, Thomas J. Kelly, S. Hurley, Brian E. Henderson, Feras Abu Saadeh, Karen A. Cadoo, John O"Leary, Sharon O"Toole, Prognostic Significance of Circulating Tumour Cells and Disseminating Circulating Tumour Cell Clusters in Epithelial Ovarian Cancer, The Journal of Liquid Biopsy, 1, 2023, p100062 - 100062, p100062-100062Journal Article, 2023, DOI
- Ciara S. McNevin, Anna Keogh, Mutaz Mohammed Nur, Brianán McGovern, Julie McFadden, Anne"Marie Baird, Karen A. Cadoo, Sarah Mc Carron, Cathal Ó"Brien, Martin P. Barr, Steven G. Gray, Orla Sheils, Lesley Ann Sutton, Sinéad Flanagan, Lorelei A. Mucci, Konrad H. Stopsack, Stephen P. Finn, Prevalence of Mismatch Repair Deficiency in Primary Prostate Cancer in a Large Prospective Cohort, Clinical Cancer Research, 31, (9), 2025, p1746 - 1753Journal Article, 2025, DOI , TARA - Full Text
- Ciara S. McNevin, Mutaz Mohammed Nur, Cathal Ó"Brien, Brianán McGovern, Julia McFadden, Anne"Marie Baird, Karen A. Cadoo, Martin P. Barr, Steven G. Gray, Anna Keogh, Orla Sheils, Lesley Ann Sutton, Sinéad Flanagan, Lorelei A. Mucci, Konrad H. Stopsack, Stephen P. Finn, Prevalence of mismatch repair deficiency in a large prospective prostate cancer cohort., Journal of Clinical Oncology, 41, (16_suppl), 2023, p5031 - 5031, p5031-5031Journal Article, 2023, DOI
- Ying L. Liu, Cara Mathews, Fiona Simpkins, Karen A. Cadoo, Diane Provencher, Colleen McCormick, Adam C. ElNaggar, Alon D. Altman, Lucy Gilbert, Destin Black, Nashwa Kabil, Rosie Taylor, Alan Barnicle, Jiefen Munley, Carol Aghajanian, Olaparib as treatment for platinum"sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis, Cancer, 131, (2), 2025Journal Article, 2025, DOI
- Ying L. Liu, Karen A. Cadoo, Anna Maio, Zalak Patel, Yelena Kemel, Erin Salo"Mullen, Amanda Catchings, Megha Ranganathan, Sarah Kane, Robert A. Soslow, Özge Ceyhan-Birsoy, Diana Mandelker, Maria I. Carlo, Michael F. Walsh, Jinru Shia, Arnold J. Markowitz, Kenneth Offit, Zsofia K. Stadler, Alicia Latham, Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome, Genetics in Medicine, 24, (6), 2022, p1187 - 1195, p1187-1195Journal Article, 2022, DOI
- Fionnuala Crowley, Karen A. Cadoo, Sarah Chiang, Diana Mandelker, Raazi Bajwa, Alexia Iasonos, Qin Zhou, Kathryn Miller, Martee L. Hensley, Roisin E. O"Cearbhaill, Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas, Gynecologic Oncology Reports, 40, 2022, p100980 - 100980, p100980-100980Journal Article, 2022, DOI
- Eugene J. Pietzak, Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Joseph Vijai, Aleksandra Walasek, Emily Bochner, Timothy N. Clinton, Nima Almassi, Hong Truong, Manuel R. de Jesus Escano, Michal Wiseman, Diana Mandelker, Yelena Kemel, Liying Zhang, Michael F. Walsh, Karen A. Cadoo, Jonathan Coleman, Hikmat Al"Ahmadie, Jonathan E. Rosenberg, Gopa Iyer, David B. Solit, Irina Ostrovnaya, Kenneth Offit, Mark E. Robson, Zsofia K. Stadler, Michael F. Berger, Dean F. Bajorin, Maria I. Carlo, Bernard H. Bochner, Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non"Muscle-Invasive Bladder Cancer, Clinical Cancer Research, 28, (19), 2022, p4267 - 4277, p4267-4277Journal Article, 2022, DOI
- Anastasia Navitski, Duaa H. Al-Rawi, Vicky Makker, Britta Weigelt, Dmitriy Zamarin, Ying L. Liu, Angela G. Arnold, M. Herman Chui, Diana Mandelker, Michael F. Walsh, Deborah F. DeLair, Karen A. Cadoo, Roisin E. O"Cearbhaill, Germline SMARCA4 Deletion as a Driver of Uterine Cancer: An Atypical Presentation, JCO Precision Oncology, (6), 2022Journal Article, 2022, DOI
- Maria M. Rubinstein, Eric Rios Doria, Jason Konner, Stuart M. Lichtman, Qin Zhou, Alexia Iasonos, Debra Sarasohn, Tiffany A. Troso-Sandoval, Claire F. Friedman, Roisin E. O"Cearbhaill, Karen A. Cadoo, Chrisann Kyi, Seth M. Cohen, Krysten Soldan, Eric Billinson, Imogen Caird, Dasom Jang, Khalil T. Eid, Pooja Shah, Joyce Guillen, Carol Aghajanian, Dmitriy Zamarin, Vicky Makker, Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study, Gynecologic Oncology, 169, 2022, p64 - 69, p64-69Journal Article, 2022, DOI
- Anastasia Navitski, Duaa H. Al-Rawi, Ying Liu, Maria M. Rubinstein, Claire F. Friedman, Raajit K. Rampal, Diana Mandelker, Karen A. Cadoo, Roisin E. O"Cearbhaill, Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer, Gynecologic Oncology Reports, 38, 2021, p100873 - 100873, p100873-100873Journal Article, 2021, DOI